title: Sirolimus-eluting stents or vascular brachytherapy for in-stent restenosis after 3-year follow-up of the SISR (Sirolimus-Eluting Stent Versus Vascular Brachytherapy for In-Stent Restenosis) trial: a call for caution?
authors.forename: Alfredo E
authors.initials: AE
authors.lastname: Rodriguez
authors.forename: Ron
authors.initials: R
authors.lastname: Waksman
mesh_terms: D001918:Brachytherapy; D023903:Coronary Restenosis / Q000188:drug therapy* / Q000517:prevention & control; D054855:Drug-Eluting Stents; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D020123:Sirolimus / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus